|
|
Prepublished online as a Blood First Edition Paper on April 17, 2002; DOI 10.1182/blood-2001-11-0087.
Previous Article | Table of Contents | Next Article 
Blood, 15 June 2002, Vol. 99, No. 12, pp. 4298-4306
CHEMOKINES
Cholesterol is essential for macrophage inflammatory protein 1
binding and conformational integrity of CC chemokine receptor
5
Dzung H. Nguyen and
Dennis Taub
From the Gerontology Research Center, National
Institute on Aging, National Institutes of Health, Baltimore, MD.
The chemokine receptor, CCR5, is used as a human immunodeficiency
virus coreceptor in combination with CD4 during transmission and early
infection. CCR5 has been shown to be palmitoylated and targeted to
cholesterol- and sphingolipid-rich membrane microdomains termed
"lipid rafts." However, the role of cholesterol and lipid rafts on
chemokine binding and signaling through CCR5 remains unknown. We found
that cholesterol extraction by hydroxypropyl- -cyclodextrin (BCD)
significantly reduced the binding and signaling of macrophage inflammatory protein 1 (MIP-1 ) using CCR5-expressing CEM-NKR T
cells. Reloading treated cells with cholesterol but not
4-cholesten-3-one, an oxidized form of cholesterol, restored MIP-1
binding to BCD-treated cells. Antibodies specific for distinct CCR5
epitopes lost their ability to bind to the cell surface after
cholesterol extraction to varying degrees. Moreover, cells stained with
fluorescently labeled MIP-1 extensively colocalized with the GM1
lipid raft marker while using anti-CCR5 antibodies; most of CCR5 on
these cells only partially colocalized with GM1, suggesting that active ligand binding facilitates receptor association with lipid rafts or
that raft association promotes a higher affinity conformation of CCR5.
Together, these data demonstrate that cholesterol and lipid rafts are
important for the maintenance of the CCR5 conformation and are
necessary for both the binding and function of this chemokine receptor.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Meiser, A. Mueller, E. L. Wise, E. M. McDonagh, S. J. Petit, N. Saran, P. C. Clark, T. J. Williams, and J. E. Pease
The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
J. Immunol.,
May 15, 2008;
180(10):
6713 - 6724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yoon, A. Terada, and H. Kita
CD66b Regulates Adhesion and Activation of Human Eosinophils
J. Immunol.,
December 15, 2007;
179(12):
8454 - 8462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Finnegan, S. S. Rawat, E. H. Cho, D. L. Guiffre, S. Lockett, A. H. Merrill Jr., and R. Blumenthal
Sphingomyelinase Restricts the Lateral Diffusion of CD4 and Inhibits Human Immunodeficiency Virus Fusion
J. Virol.,
May 15, 2007;
81(10):
5294 - 5304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Imhoff, V. von Messling, G. Herrler, and L. Haas
Canine Distemper Virus Infection Requires Cholesterol in the Viral Envelope
J. Virol.,
April 15, 2007;
81(8):
4158 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gaibelet, T. Planchenault, S. Mazeres, F. Dumas, F. Arenzana-Seisdedos, A. Lopez, B. Lagane, and F. Bachelerie
CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH
J. Biol. Chem.,
December 8, 2006;
281(49):
37921 - 37929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jandu, P. J. M. Ceponis, S. Kato, J. D. Riff, D. M. McKay, and P. M. Sherman
Conditioned Medium from Enterohemorrhagic Escherichia coli-Infected T84 Cells Inhibits Signal Transducer and Activator of Transcription 1 Activation by Gamma Interferon
Infect. Immun.,
March 1, 2006;
74(3):
1809 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank
Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol
J. Immunol.,
February 15, 2006;
176(4):
2337 - 2345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chakraborty, S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy
Leishmania donovani Affects Antigen Presentation of Macrophage by Disrupting Lipid Rafts
J. Immunol.,
September 1, 2005;
175(5):
3214 - 3224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiao, N. Zhang, X. Xu, J. J. Oppenheim, and T. Jin
Ligand-Induced Partitioning of Human CXCR1 Chemokine Receptors with Lipid Raft Microenvironments Facilitates G-Protein-Dependent Signaling
Mol. Cell. Biol.,
July 1, 2005;
25(13):
5752 - 5762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Signoret, L. Hewlett, S. Wavre, A. Pelchen-Matthews, M. Oppermann, and M. Marsh
Agonist-induced Endocytosis of CC Chemokine Receptor 5 Is Clathrin Dependent
Mol. Biol. Cell,
February 1, 2005;
16(2):
902 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Pulfer, C. Taube, E. Gelfand, and R. C. Murphy
Ozone Exposure in Vivo and Formation of Biologically Active Oxysterols in the Lung
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
256 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Finnegan, S. S. Rawat, A. Puri, J. M. Wang, F. W. Ruscetti, and R. Blumenthal
Ceramide, a target for antiretroviral therapy
PNAS,
October 26, 2004;
101(43):
15452 - 15457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Steffens and T. J. Hope
Mobility of the Human Immunodeficiency Virus (HIV) Receptor CD4 and Coreceptor CCR5 in Living Cells: Implications for HIV Fusion and Entry Events
J. Virol.,
September 1, 2004;
78(17):
9573 - 9578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Popik and T. M. Alce
CD4 Receptor Localized to Non-raft Membrane Microdomains Supports HIV-1 Entry: IDENTIFICATION OF A NOVEL RAFT LOCALIZATION MARKER IN CD4
J. Biol. Chem.,
January 2, 2004;
279(1):
704 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Slimani, N. Charnaux, E. Mbemba, L. Saffar, R. Vassy, C. Vita, and L. Gattegno
Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells
Glycobiology,
September 1, 2003;
13(9):
623 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Venkatesan, J. J. Rose, R. Lodge, P. M. Murphy, and J. F. Foley
Distinct Mechanisms of Agonist-induced Endocytosis for Human Chemokine Receptors CCR5 and CXCR4
Mol. Biol. Cell,
August 1, 2003;
14(8):
3305 - 3324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. von Lindern, D. Rojo, K. Grovit-Ferbas, C. Yeramian, C. Deng, G. Herbein, M. R. Ferguson, T. C. Pappas, J. M. Decker, A. Singh, et al.
Potential Role for CD63 in CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection of Macrophages
J. Virol.,
March 15, 2003;
77(6):
3624 - 3633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Percherancier, B. Lagane, T. Planchenault, I. Staropoli, R. Altmeyer, J.-L. Virelizier, F. Arenzana-Seisdedos, D. C. Hoessli, and F. Bachelerie
HIV-1 Entry into T-cells Is Not Dependent on CD4 and CCR5 Localization to Sphingolipid-enriched, Detergent-resistant, Raft Membrane Domains
J. Biol. Chem.,
January 24, 2003;
278(5):
3153 - 3161.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |